HA
Hugo J.A. Adams

Highly Cited


129
Works
2,123
Citations
24
H-Index
Search Authors
Author Statistics

Hugo J.A. Adams

Also known as: Adams, Hugo J A, Adams, Hugo J. A., H.J.A. Adams, Hugo J A Adams, Hugo J. A. Adams

129

Total Works

2,123

Citations

24

H-Index

43

i10-Index

Citation & Works Trend by Year
14 years active
Top Research Topics
Lymphoma Diagnosis and Treatment (111) Medical Imaging Techniques and Applications (94) Hematological disorders and diagnostics (69) CNS Lymphoma Diagnosis and Treatment (14) Chronic Lymphocytic Leukemia Research (11)
Recent Publications
15 shown
Year Publication Title Citations Action
2021 Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis European Radiology 72
2021 Response CHEST Journal 0
2021 Diagnostic Performance of CO-RADS and the RSNA Classification System in Evaluating COVID-19 at Chest CT: A Meta-Analysis Radiology Cardiothoracic Imaging 36
2020 Chest CT in Patients with COVID-19: Toward a Better Appreciation of Study Results and Clinical Applicability Radiology 2
2020 Peer review practices by medical imaging journals Insights into Imaging 8
2020 Chest CT Imaging Signature of Coronavirus Disease 2019 Infection CHEST Journal 120
2020 Systematic Review and Meta-Analysis on the Value of Chest CT in the Diagnosis of Coronavirus Disease (COVID-19): Sol Scientiae, Illustra Nos American Journal of Roentgenology 65
2020 Coronavirus Disease 2019 and Chest CT: Do Not Put the Sensitivity Value in the Isolation Room and Look Beyond the Numbers Radiology 15
2020 Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment Journal of Clinical Oncology 1
2019 Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients Annals of Hematology 9
2019 Only a Small Proportion of Patients With Early-Stage Hodgkin Lymphoma May Potentially Benefit From Fluorodeoxyglucose-Positron Emission Tomography–Adapted Treatment Escalation Journal of Clinical Oncology 2
2019 Value of detecting bone marrow involvement in Hodgkin lymphoma British Journal of Haematology 2
2019 Proportion of false-positive follow-up FDG-PET scans in lymphoma: Systematic review and meta-analysis Critical Reviews in Oncology/Hematology 18
2019 A 73% Price Reduction Does Not Indisputably Justify Routine Application of Brentuximab Vedotin as First-Line Treatment of Hodgkin Lymphoma Journal of Clinical Oncology 2
2019 Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma? The Lancet Oncology 0

Data source: OpenAlex API